Table of Contents

    Topic review

    AIRE Gene

    View times: 6
    Submitted by: Bruce Ren
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    autoimmune regulator

    1. Normal Function

    The AIRE gene provides instructions for making a protein called the autoimmune regulator. This protein is active primarily in the thymus, which is an organ located behind the breastbone that plays an important role in immune system function. The thymus prepares immune cells called T cells for their role in fighting infection; this process is called thymic education.

    For a person to remain healthy, immune system cells such as T cells must be able to identify and destroy potentially harmful invaders (such as bacteria, fungi, and viruses) while sparing the body's normal tissues. The autoimmune regulator protein plays an important role in this process by helping T cells distinguish the body's own proteins from those of foreign invaders. When this system malfunctions, the immune system's ability to distinguish between the body's proteins and foreign invaders is impaired, and it may attack the body's own tissues and organs. This abnormal reaction is called autoimmunity. In the thymus, the autoimmune regulator protein destroys T cells that otherwise would cause autoimmune damage.

    2. Health Conditions Related to Genetic Changes

    2.1 Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

    More than 90 mutations in the AIRE gene have been identified in people with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). APECED is an inherited condition that affects many of the body's organs. A major feature of this disorder is chronic mucocutaneous candidiasis (CMC), which is a tendency to develop infections of the skin, the nails, and the moist lining of body cavities (mucous membranes) caused by a type of fungus called Candida. Other common signs and symptoms of APECED involve dysfunction of the body's network of hormone-producing glands (the endocrine system), as well as other organs and tissues.

    The AIRE gene mutations that cause APECED lead to the production of an abnormally short, nonfunctional version of the autoimmune regulator protein or change single protein building blocks (amino acids) in critical regions of the protein. These mutations reduce or eliminate the function of the autoimmune regulator protein. Without enough of this protein function, the immune system's ability to distinguish between the body's proteins and foreign invaders is impaired, and immune cells may attack the body's own organs, resulting in autoimmunity. This abnormal reaction leads to inflammation and can damage otherwise healthy cells and tissues. Autoimmune damage to the adrenal glands, parathyroid glands, and other organs underlies many of the major features of APECED.

    Studies suggest that AIRE gene mutations also result in immune substances (antibodies) mistakenly attacking proteins involved in an immune process called the IL-17 pathway, which is important in the body's defense against Candida. This pathway, which depends on specialized proteins called IL-17 cytokines for signaling, creates inflammation, sending additional cytokines and white blood cells to fight foreign invaders and promote tissue repair. In addition, the IL-17 pathway promotes the production of certain antimicrobial protein segments (peptides) that control growth of Candida on the surface of mucous membranes. By damaging IL-17 cytokines, AIRE gene mutations are thought to impair the IL-17 pathway's function, resulting in CMC in people with APECED.

    2.2 Alopecia areata

    MedlinePlus Genetics provides information about Alopecia areata

    3. Other Names for This Gene

    • AIRE1
    • AIRE_HUMAN
    • APECED
    • APS1
    • APSI
    • Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein
    • PGA1

    The entry is from https://medlineplus.gov/genetics/gene/aire

    References

    1. Anderson MS, Su MA. AIRE expands: new roles in immune tolerance and beyond.Nat Rev Immunol. 2016 Apr;16(4):247-58. doi: 10.1038/nri.2016.9.
    2. De Martino L, Capalbo D, Improda N, D'Elia F, Di Mase R, D'Assante R, D'AcunzoI, Pignata C, Salerno M. APECED: A Paradigm of Complex Interactions betweenGenetic Background and Susceptibility Factors. Front Immunol. 2013 Oct 23;4:331. doi: 10.3389/fimmu.2013.00331. Review.
    3. De Martino L, Capalbo D, Improda N, Lorello P, Ungaro C, Di Mase R, Cirillo E,Pignata C, Salerno M. Novel Findings into AIRE Genetics and Functioning: ClinicalImplications. Front Pediatr. 2016 Aug 22;4:86. doi: 10.3389/fped.2016.00086.
    4. Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB,Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, CollarAL, Kong HH, Lee CR, Chascsa D, Simcox T, Pham A, Bondici A, Natarajan M, MonsaleJ, Kleiner DE, Quezado M, Alevizos I, Moutsopoulos NM, Yockey L, Frein C,Soldatos A, Calvo KR, Adjemian J, Similuk MN, Lang DM, Stone KD, Uzel G, Kopp JB,Bishop RJ, Holland SM, Olivier KN, Fleisher TA, Heller T, Winer KK, Lionakis MS. Redefined clinical features and diagnostic criteria in autoimmunepolyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016 Aug18;1(13). pii: e88782.
    5. Gallo V, Giardino G, Capalbo D, Palamaro L, Romano R, Santamaria F, Maio F,Salerno M, Vajro P, Pignata C. Alterations of the autoimmune regulatortranscription factor and failure of central tolerance: APECED as a model. Expert Rev Clin Immunol. 2013 Jan;9(1):43-51. doi: 10.1586/eci.12.88. Review.
    6. Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E,Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R,Ergun-Longmire B, Maclaren N, Krohn KJ, Pura M, Schalke B, Ströbel P, Leite MI,Battelino T, Husebye ES, Peterson P, Willcox N, Meager A. Chronic mucocutaneouscandidiasis in APECED or thymoma patients correlates with autoimmunity toTh17-associated cytokines. J Exp Med. 2010 Feb 15;207(2):299-308. doi:10.1084/jem.20091669.
    7. Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermaldystrophy. J Clin Immunol. 2015 Jul;35(5):463-78. doi: 10.1007/s10875-015-0176-y.
    8. Laan M, Peterson P. The many faces of aire in central tolerance. FrontImmunol. 2013 Oct 11;4:326. doi: 10.3389/fimmu.2013.00326. Review.
    9. Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C,Cobat A, Ouachée-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M,Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougnères PF, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C,Abel L, Lilic D, Casanova JL. Autoantibodies against IL-17A, IL-17F, and IL-22 inpatients with chronic mucocutaneous candidiasis and autoimmune polyendocrinesyndrome type I. J Exp Med. 2010 Feb 15;207(2):291-7. doi: 10.1084/jem.20091983.
    More

    Keywords

    1. Please check and comment entries here.